Janssen-cilag Ltd.
Clinical trials sponsored by Janssen-cilag Ltd., explained in plain language.
-
Psoriasis patients switch biologics in new observational study
Disease control Recruiting nowThis study follows 200 adults with moderate to severe psoriasis who switch from ustekinumab to guselkumab in routine care. Researchers will track how well the new drug controls skin symptoms and monitor for side effects over 52 weeks. The goal is to see if guselkumab is a safe an…
Sponsor: Janssen-Cilag Ltd. • Aim: Disease control
Last updated Apr 26, 2026 20:03 UTC
-
New immune therapies for Hard-to-Treat myeloma: how well do they work in real life?
Knowledge-focused Recruiting nowThis study looks at how well two new immune therapies, teclistamab and talquetamab, work for people with relapsed/refractory multiple myeloma (RRMM) when used outside of clinical trials. Researchers will review medical records from about 900 patients across several countries to s…
Sponsor: Janssen-Cilag Ltd. • Aim: Knowledge-focused
Last updated Apr 29, 2026 02:06 UTC